HIF1A and hepatocellular carcinoma: To further explore whether GSTZ1 deficiency contributes to HCC angiogenesis through HIF-1α activation, and whether combined targeting of HIF-1α and PD-L1 can improve the antiangiogenesis efficacy of HCC in vivo, we used the DEN/CCl4-induced HCC mouse model.